Last Updated on October 6, 2024 by The Health Master
Medicine supplies to Brazil
In a notable collaboration that could reshape the pharmaceutical landscape, a prominent Brazilian enterprise, Register Medical Group (RMG), has initiated discussions with Indian drug manufacturers to procure a diverse range of vital medications.
The acquisition encompasses 24 distinct categories of medicines designed to address an array of health concerns, spanning blood thinners, acidity, bacterial and fungal infections, as well as gastrointestinal and respiratory infections.
Strategic Partnership Aims to Elevate Medical Access
The Pharmaceutical Export Promotion Council of India (Pharmexcil) has officially revealed the intention of RMG to establish a productive alliance with an Indian pharmaceutical company.
This strategic alliance would facilitate the importation and distribution of the specified medications within Brazil.
According to Pharmexcil, the Indian embassy located in Brasilia has forwarded communication detailing this promising trade inquiry from the Brazilian conglomerate.
Wide-ranging Medications to Address Diverse Health Needs
The comprehensive list of pharmaceutical products sought by RMG encompasses a range of crucial medical solutions.
These products include:
- Ceftriaxone 1000mg: A potent antibiotic renowned for its efficacy in combating bacterial infections affecting diverse bodily regions, including the lungs, throat, ears, heart, skin, and urinary tract.
- Ceftazidima 1000mg: A specialized medication tailored to treat a spectrum of bacterial infections. Its applications span pneumonia, lower respiratory tract infections, meningitis, and other infections impacting the brain and spinal cord.
- Pantoprazol 40mg: A versatile medication that provides relief from heartburn, acid reflux, and gastro-oesophageal reflux disease (GORD). Additionally, it is employed in the prevention and treatment of stomach ulcers.
- AlbuminaHumana 20% C/01 f/a 50 ml IV: Human albumin, a critical component in medical treatments, is utilized to address specific medical conditions.
- Ampicilina+Sulbactam Inj. 3G S/Dil (Gen): A pharmaceutical solution designed to combat various bacterial infections, including those affecting the skin, female reproductive organs, and the abdominal region.
- Cefepima (Gen) 1G PO IM/IV FR-AMP: A potent injection serving as a frontline defense against severe bacterial infections. Its applications extend to skin, lungs, stomach, urinary tract, and blood infections.
- Claritromicina 500mg Inj IV f/a: Targeted at chest infections like pneumonia, skin issues including cellulitis, and ear infections, this medication also proves effective in addressing Helicobacter pylori-related concerns.
- Enoxaparina 20mg: A pivotal medication dedicated to preventing and treating harmful blood clots, thereby mitigating the risk of strokes or heart attacks.
- Ertapenem Sodico 1gr Im/Iv Inj C/1f/A (Gen): Designed to tackle serious bacterial infections spanning various bodily regions, such as pneumonia, urinary tract, skin, diabetic foot conditions, gynecological concerns, and abdominal infections.
- Heparina Sod. 5000ui F/A 5ml (Hepamax-S): A crucial anti-coagulant solution with numerous applications in medical care.
- Imunoglobulina Humana 5g F/A 100ml (Immugl): A specialized medication catering to patients dealing with primary humoral immunodeficiency (PI), idiopathic thrombocytopenic purpura (ITP), and other conditions.
- Meropenem Inj 1g F/A S/Dil (Gen): Targeted at skin and abdominal infections caused by bacteria, as well as meningitis.
- Piperacilina+Tazobac. 4g+500mg S/Dil. (Gen): A combined injection addressing bacterial infections in various bodily regions, including the stomach, bowel, lungs, skin, and female reproductive organs.
- Propofol Inj. 10mg Iv 20ml (C1) (Gen): A crucial medication used for anesthesia induction.
- Tenoxicam Inj. 40mg F/A+Dilx2ml (Gen): An anti-inflammatory analgesic effectively combating mild to moderate pain and the symptoms of arthritis.
- Teicoplanina Inj. 400mg f/a S/Dil (Gen): An essential solution tailored to treat bacterial infections of the skin and underlying soft tissues.
- Voriconazol Po Inj. 200g c/1 f/a (Gen): A medication specializing in the treatment of severe fungal or yeast infections.
Seizing the Opportunity
Uday Bhaskar, the Director General of Pharmexcil, has emphasized the unique prospect presented by this collaboration.
He encourages member companies to actively engage with RMG, taking full advantage of this strategic opportunity.
Bhaskar also highlights the avenue for direct communication with the Brazilian company via the Indian Embassy in Brazil.
As this promising collaboration between Register Medical Group and Indian pharmaceutical manufacturers unfolds, it promises not only enhanced medical accessibility but also an exciting gateway for both nations to foster a mutually beneficial partnership in the pharmaceutical domain.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model, to rewrite and present the news / article in a unique format.
Govt introduces Pharmacy (Amendment) Bill 2023
USFDA completes PADE inspection at Marksans with 2 observations
32 MSMEs selected for pharma PLI schemes: Govt
Pharma Industry under scrutiny: Key regulatory steps by CDSCO and State Authorities
Drug recall: Lupin Pharma recalled these Birth Control Pills
India became “Aatmanirbhar: in 38 APIs: HM
Pharma Industry seeks faster export of Cough Syrups to Counter China’s Growing Dominance
USFDA issues warning letter to Intas Pharmaceuticals
Tax Dept uncovers Rs 6 Crore Tax Evasion in Pharma Companies: Uttrakhand
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
